Rôle de l'herpèsvirus humain de type 6 dans le ... - Epublications

Watanabe, K., Yamashita, Y., Nakayama, A., Hasegawa, Y., Kojima, H., Nagasawa, T. &
Mori, N. (2000). Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in
classic Hodgkin's disease. Histopathology 36, 353-361.
Watanabe, M., Ogawa, Y., Ito, K., Higashihara, M., Kadin, M. E., Abraham, L. J.,
Watanabe, T. & Horie, R. (2003). AP-1 mediated relief of repressive activity of the
CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am J Pathol 163,
633-641.
Weniger, M. A., Melzner, I., Menz, C. K., Wegener, S., Bucur, A. J., Dorsch, K., Mattfeldt,
T., Barth, T. F. & Moller, P. (2006). Mutations of the tumor suppressor gene SOCS-1 in
classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5
accumulation. Oncogene 25, 2679-2684.
Williams, S. L., Hartline, C. B., Kushner, N. L., Harden, E. A., Bidanset, D. J., Drach, J. C.,
Townsend, L. B., Underwood, M. R., Biron, K. K. & Kern, E. R. (2003). In vitro
activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob
Agents Chemother 47, 2186-2192.
Wong, G. A. & Shear, N. H. (2004). Is a drug alone sufficient to cause the drug hypersensitivity
syndrome? Arch Dermatol 140, 226-230.
Wu, Y., Sanderson, J. P., Farrell, J., Drummond, N. S., Hanson, A., Bowkett, E., Berry, N.,
Stachulski, A. V., Clarke, S. E., Pichler, W. J., Pirmohamed, M., Park, B. K. &
Naisbitt, D. J. (2006). Activation of T cells by carbamazepine and carbamazepine
metabolites. J Allergy Clin Immunol 118, 233-241.
Wu, Z., Mu, G. & Wang, L. (1997). Seroprevalence of human herpesvirus-6 in healthy
population in two provinces of north China. Chin Med Sci J 12, 111-114.
Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. & Kurata, T.
(1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum.
Lancet 1, 1065-1067.
Yao, K., Hoest, C., Rashti, F., Schott, T. C. & Jacobson, S. (2009). Effect of (r)-9-[4-hydroxy-
2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B
infected cells. J Clin Virol 46, 10-14.
Yasukawa, M., Inoue, Y., Ohminami, H., Terada, K. & Fujita, S. (1998). Apoptosis of CD4+
T lymphocytes in human herpesvirus-6 infection. J Gen Virol 79 ( Pt 1), 143-147.
Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S. & Gruss, P.
(1999). Development of peripheral lymphoid organs and natural killer cells depends on
the helix-loop-helix inhibitor Id2. Nature 397, 702-706.
Yoshida, M., Yamada, M., Tsukazaki, T., Chatterjee, S., Lakeman, F. D., Nii, S. & Whitley,
R. J. (1998). Comparison of antiviral compounds against human herpesvirus 6 and 7.
Antiviral Res 40, 73-84.
Yoshikawa, T. (2003). Significance of human herpesviruses to transplant recipients. Curr Opin
Infect Dis 16, 601-606.
Yoshikawa, T., Akimoto, S., Nishimura, N., Ozaki, T., Ihira, M., Ohashi, M., Morooka, M.,
Suga, S., Asano, Y., Takemoto, M. & Nishiyama, Y. (2003). Evaluation of active
human herpesvirus 6 infection by reverse transcription-PCR. J Med Virol 70, 267-272.
Yoshikawa, T. & Asano, Y. (2000). Central nervous system complications in human
herpesvirus-6 infection. Brain Dev 22, 307-314.
Yoshikawa, T., Fujita, A., Yagami, A., Suzuki, K., Matsunaga, K., Ihira, M. & Asano, Y.
(2006). Human herpesvirus 6 reactivation and inflammatory cytokine production in
patients with drug-induced hypersensitivity syndrome. J Clin Virol 37 Suppl 1, S92-96.
181